MachFBaigentCCatapanoAL, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur Heart J2020; 41: 111–188.
2.
GornikHLAronowHDGoodneyPP, et al. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS guideline for the management of lower extremity peripheral artery disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation2024; 149: e1313–e1410.
3.
HessCNCannonCPBeckmanJA, et al. Effectiveness of blood lipid management in patients with peripheral artery disease. J Am Coll Cardiol2021; 77: 3016–3027.
4.
HessCNDaffronANehlerMR, et al. Randomized trial of a vascular care team vs education for patients with peripheral artery disease. J Am Coll Cardiol2024; 83: 2658–2670.
5.
GrundySMStoneNJBaileyAL, et al. 2018 guideline on the management of blood cholesterol. Circulation2019; 139: e1082–e1143.
